— Know what they know.
Not Investment Advice
Also trades as: ALVO (NASDAQ) · $vol 5M

ALVOW NASDAQ

Alvotech
1W: -61.4% 1M: -43.3% 3M: -15.7% YTD: -78.2% 1Y: -85.2% 3Y: -88.7%
$0.17
-0.03 (-14.96%)
 
Weekly Expected Move ±62.4%
$-0 $0 $0 $1 $1
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 30 · $1.6B mcap · 103M float · 0.0037% daily turnover · Short 59% of daily vol
Credit Risk of going bust: higher than 88% of companies Debt: 46.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.02 (down 90%), Alvotech would be worth roughly what it owes.
Total debt $1.45B against a stock market value of $1.69B.
Distance to default 1.86 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $685.8M (short-term plus half of long-term), stock volatility 81.2%; Altman Z'' -4.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Cash Flow Trends

Operating Cash Flow
-$50M +78.8% ▲
Capital Expenditures
$64M -13.1% ▼
5Y CAGR: +40.0%
Free Cash Flow
-$115M +61.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$121M +200.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$102M-$514M-$552M-$232M$28M
Depreciation & Amort.$18M$20M$24M$31M$38M
Stock-Based Comp.$0$10M$18M$8M$17M
Change in Working Capital-$7M-$48M$26M-$289M-$118M
Other Non-Cash Items-$90M$256M$270M$230M-$124M
Operating Cash Flow-$228M-$312M-$312M-$237M-$50M
— Investing Activities —
Capital Expenditures-$20M-$38M-$33M-$54M-$64M
Acquisitions (Net)$0$0$0$12M-$14M
Investment Purchases$0$0$0$0-$32M
Investment Sales$0$0$0$0$6M
Other Investing-$20M-$26M-$13M$23M$0
Investing Cash Flow-$41M-$64M-$46M-$19M-$104M
— Financing Activities —
Net Debt Issuance$69M$258M$171M$152M$202M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$157M-$7M-$5M-$10M
Financing Cash Flow$255M$425M$301M$297M$271M
Net Change in Cash-$14M$49M-$55M$40M$121M
Cash End of Period$18M$66M$11M$51M$172M
Free Cash Flow-$269M-$361M-$359M-$294M-$115M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms